Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News FAQ
On This Report

Artificial Intelligence (AI) in Healthcare Market Size & Growth Forecast 2027–2036, By Segments (Component, Technology, End Use, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 7033| Published Date: Sep-2026| Format: PDF, Excel
Market Outlook

Market Size and Growth Outlook

Artificial Intelligence in Healthcare Market size was estimated at USD 50.7 billion in 2026 and is projected to grow at a 36.96% CAGR from 2027 to 2036, reaching USD 1.18 trillion by 2036. The industry revenue for 2027 is calculated at USD 66.48 billion.

Base Year Value (2026)
USD 50.7 billion
CAGR (2027-2036)
36.96%
Forecast Year Value (2036)
USD 1.18 trillion
Historical Data Period
2022-2026
Largest Region
North America
Forecast Period
2027-2036

Get more details on this report

Request Free Sample Report
Snapshot

Artificial Intelligence (AI) in Healthcare Market Intelligence Snapshot

Regional Market Dynamics

  • North America captured 56.70% share in 2026 through advanced healthcare infrastructure, AI integration across workflows, and strong technology investment ecosystems.
  • Asia Pacific is growing at a 41.03% CAGR as healthcare systems adopt AI for diagnostics, automation, and data-driven care management.

Segment Momentum

  • Software Solutions captured a 48.76% share in 2026 by serving as the primary platform for integrating AI algorithms, clinical workflows, imaging, and decision-support tools into existing healthcare infrastructure.
  • Context-Aware Computing is growing rapidly because healthcare providers increasingly require AI systems that adapt to changing patient and care environments, delivering more responsive and situationally relevant insights.

Market Expansion Drivers

  • AI-driven clinical decision support enhancing diagnostics accuracy and treatment efficiency.
  • Expanding healthcare data from EHRs, imaging, and genomics enabling predictive AI insights.
  • Healthcare workforce shortages accelerating automation and AI-assisted clinical workflows.

Leading Market Participants

  • Key players in the artificial intelligence in healthcare market include Microsoft Corporation (United States), Alphabet Inc. (United States), IBM Corporation (United States), NVIDIA Corporation (United States), Intel Corporation (United States), GE HealthCare Technologies Inc. (United States), Medtronic plc (Ireland), Oracle Corporation (United States), IQVIA Holdings Inc. (United States), Merck & Co., Inc. (United States).

Forecast Snapshot

Global Market Forecast Snapshot

Market Outlook

  • 2026 Market Size: USD 50.7 billion
  • 2027 Estimated Market Size: USD 66.48 billion.
  • Projected Market Size: USD 1.18 trillion by 2036
  • Growth Forecast: 36.96% CAGR (2027-2036)

Regional and Segment Outlook

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Software Solutions (Component) | Machine Learning (Technology) | Healthcare Companies (End Use) | Robot Assisted Surgery (Application)
  • Emerging Opportunity Segment: Services (Component) | Context-Aware Computing (Technology) | Healthcare Providers (End Use) | Fraud Detection (Application)
Market Dynamics

Market Growth Drivers and Industry Trends

AI-driven clinical decision support enhancing diagnostics accuracy and treatment efficiency

AI-driven clinical decision support is strengthening the artificial intelligence in healthcare market by helping healthcare professionals analyze complex clinical information and identify relevant diagnostic and treatment insights. These systems can support the interpretation of medical information, assist with disease identification, and help clinicians evaluate treatment options more efficiently. By augmenting clinical expertise with data-driven recommendations, AI tools can streamline decision-making while supporting more consistent and efficient patient care.

Expanding healthcare data from EHRs, imaging, and genomics enabling predictive AI insights

The growing availability of electronic health records, medical imaging, and genomic information is creating a broader foundation for the artificial intelligence in healthcare market. AI systems can process large and diverse datasets to identify patterns that may be difficult to detect through conventional analysis, supporting predictive insights related to disease risks, patient outcomes, and treatment responses. The integration of these data sources also enables healthcare organizations to develop more informed approaches to clinical assessment and patient management.

Healthcare workforce shortages accelerating automation and AI-assisted clinical workflows

Healthcare workforce shortages are encouraging greater adoption of the artificial intelligence in healthcare market as providers seek technologies that can reduce repetitive workloads and support clinical staff. AI-assisted workflows can automate administrative and analytical tasks, facilitate information processing, and help healthcare professionals manage larger volumes of patient-related activities. Such capabilities can allow clinical teams to devote more time to patient-facing responsibilities while maintaining access to relevant information during routine healthcare processes.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
AI-driven clinical decision support enhancing diagnostics accuracy and treatment efficiency 2.40% High North America, Europe High Near Term
Expanding healthcare data from EHRs, imaging, and genomics enabling predictive AI insights 2.10% High North America, Asia Pacific High Mid Term
Healthcare workforce shortages accelerating automation and AI-assisted clinical workflows 1.90% High North America, Europe, Asia Pacific High Near Term
Custom Research

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
Regional Forecast

Regional Demand Dynamics

Artificial Intelligence (AI) in Healthcare Market
Largest Region
North America
56.7% Market Share in 2026

North America (Largest Region)

The artificial intelligence in healthcare market was led by North America, which held a 56.70% share in 2026. The region benefits from advanced healthcare infrastructure, strong adoption of digital health technologies, and substantial investment in artificial intelligence applications across clinical and administrative workflows. Healthcare providers are increasingly using AI for medical imaging, diagnostics, patient monitoring, drug discovery, and personalized care, while health organizations are also applying intelligent systems to streamline documentation and operational processes. A mature technology ecosystem, growing integration of electronic health data, and continued emphasis on improving clinical efficiency are supporting broader implementation. Regulatory developments and increasing attention to responsible AI deployment are also encouraging healthcare institutions to adopt solutions with stronger standards for safety, interoperability, and data governance.

Asia Pacific (Fastest-Growing Region)

Asia Pacific is the fastest-growing region, supported by expanding digital healthcare infrastructure, rising healthcare demand, and increasing investments in artificial intelligence capabilities. Healthcare systems across the region are adopting AI to improve diagnostic accessibility, support clinical decision-making, manage growing patient volumes, and address disparities in access to specialized expertise. The expansion of connected health platforms, electronic medical records, and cloud-based healthcare services is creating a stronger foundation for AI integration. In addition, government-led digital transformation initiatives and growing interest in advanced medical technologies are encouraging healthcare providers and technology stakeholders to incorporate AI into both clinical and operational applications.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
Country Insights

Key Country Insights

Germany 🇩🇪

Hospital Automation Focus

Germany emphasizes AI deployment that strengthens hospital efficiency, medical imaging analysis, and clinical decision support. The artificial intelligence in healthcare market in Germany benefits from collaboration between healthcare institutions and technology developers to enable practical implementation.

France 🇫🇷

Data-Driven Care Delivery

France focuses on expanding AI applications that enhance diagnostic accuracy and healthcare resource management. Artificial intelligence in healthcare initiatives in France increasingly emphasize secure patient data utilization alongside responsible clinical implementation.

Italy 🇮🇹

Diagnostic Workflow Enhancement

Italy is incorporating artificial intelligence into diagnostic imaging, hospital administration, and patient management systems. The artificial intelligence in healthcare market in Italy continues emphasizing scalable digital solutions that improve healthcare efficiency and clinical consistency.

Japan 🇯🇵

Aging Care Intelligence

Japan applies artificial intelligence in healthcare to support aging populations through predictive diagnostics, remote monitoring, and care optimization. Healthcare organizations in Japan increasingly adopt AI-enabled solutions that improve patient management while reducing operational burdens.

South Korea 🇰🇷

Digital Health Innovation

South Korea advances artificial intelligence in healthcare through connected hospitals, digital diagnostics, and AI-assisted clinical services. The country continues strengthening healthcare technology ecosystems that accelerate deployment of intelligent medical solutions across care settings.

United States 🇺🇸

Clinical AI Integration

The U.S. artificial intelligence in healthcare market prioritizes integrating AI into clinical workflows, diagnostics, and hospital operations. Healthcare providers in the U.S. continue investing in interoperable platforms that improve decision support while maintaining data security and regulatory compliance.

Segment Analysis

Segment Leadership and Growth Trends

Artificial Intelligence (AI) in Healthcare Market Share (%), by Component, 2026

Software Solutions
Services
Hardware

Go beyond the chart, access full insights & data tables

Request Free Sample Report

Component Segment Analysis: Software Solutions (Largest Segment) vs Services (Fastest-Growing Segment)

Software solutions represented the largest component segment of the artificial intelligence (AI) in healthcare market, accounting for a 48.76% share in 2026. Their leading position reflects the central role of AI platforms and applications in enabling healthcare organizations to apply machine intelligence to clinical, administrative, and operational activities. AI software can support tasks such as data analysis, decision support, workflow optimization, and pattern recognition, helping healthcare institutions manage increasingly complex information environments. Continued digital transformation and growing demand for technology-enabled healthcare processes are strengthening the deployment of AI software across a broad range of applications.

Services are the fastest-growing component segment as healthcare organizations increasingly require specialized support to implement, integrate, maintain, and optimize AI technologies. Deploying AI effectively often involves adapting solutions to existing workflows, data environments, and organizational requirements, creating demand for consulting, implementation, training, and managed services. As healthcare providers and other stakeholders move from experimentation toward broader operational use of AI, the need for specialized expertise is increasing. This transition is supporting stronger demand for services that help organizations maximize the practical value of AI investments.

Technology Segment Analysis: Machine Learning (Largest Segment) vs Context-Aware Computing (Fastest-Growing Segment)

Machine learning held the largest share of the artificial intelligence (AI) in healthcare market at 37.1% in 2026, reflecting its broad applicability across healthcare data analysis and decision-support use cases. Machine learning enables systems to identify patterns within complex datasets and support predictive or analytical processes, making it valuable across clinical and operational environments. The increasing availability of digital healthcare data and the industry's focus on improving data-driven decision-making are supporting widespread use of machine learning technologies. Its versatility across multiple healthcare applications continues to underpin its leading position.

Context-aware computing is the fastest-growing technology segment as healthcare AI increasingly moves toward systems capable of interpreting information within the circumstances surrounding a patient, user, or operational event. Context-aware technologies can support more responsive and personalized interactions by considering relevant environmental, behavioral, or situational information alongside conventional data inputs. Growing demand for intelligent healthcare systems that can deliver more timely and relevant insights is encouraging adoption of these capabilities, particularly as healthcare organizations pursue more personalized and adaptive digital experiences.

Segment Sub-Segment Largest Segment Fastest Growing
Component Hardware, Software Solutions, Services Software Solutions Services
Technology Machine Learning, Natural Language Processing, Context-Aware Computing, Computer Vision Machine Learning Context-Aware Computing
End Use Healthcare Providers, Healthcare Payers, Healthcare Companies, Patients, Others Healthcare Companies Healthcare Providers
Application Robot Assisted Surgery, Virtual Assistants, Administrative Workflow Assistants, Connected Medical Devices, Medical Imaging & Diagnostics, Clinical Trials, Fraud Detection, Cybersecurity, Dosage Error Reduction, Precision Medicine, Drug Discovery & Development, Lifestyle Management & Remote Patient Monitoring, Wearables, Others Robot Assisted Surgery Fraud Detection
Competitive Landscape

Competitive Landscape and Market Positioning

Top players in the artificial intelligence (AI) in healthcare market:

1. Microsoft Corporation (United States)

2. Alphabet Inc. (United States)

3. IBM Corporation (United States)

4. NVIDIA Corporation (United States)

5. Intel Corporation (United States)

6. GE HealthCare Technologies Inc. (United States)

7. Medtronic plc (Ireland)

8. Oracle Corporation (United States)

9. IQVIA Holdings Inc. (United States)

10. Merck & Co. Inc. (United States)

The AI in healthcare market is rapidly evolving with intelligent systems that improve diagnostics, treatment planning, and operational efficiency in clinical environments. Strong R&D focus is enhancing predictive accuracy and decision support capabilities. Collaborative initiatives between healthcare providers and technology firms are accelerating adoption, while new AI-driven solutions are expanding clinical applications.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
Microsoft Corporation (United States)
Alphabet Inc. (United States)
IBM Corporation (United States)
NVIDIA Corporation (United States)
Intel Corporation (United States)
GE HealthCare Technologies Inc. (United States)
Medtronic plc (Ireland)
Oracle Corporation (United States)
IQVIA Holdings Inc. (United States)
Merck & Co. Inc. (United States).
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
Microsoft Mar-26 Microsoft launched an upgraded version of Copilot Health that establishes direct, continuous data integration with electronic health records, lab results, and patient wearables. The product launch delivers an advanced clinical decision-support layer, strengthening enterprise clinician workflows and patient engagement.
Hallym University Hospital & Vuno Dec-25 Hallym University Hospital deployed Vuno's specialized stroke artificial intelligence software across its clinical operations. This technology integration enables the rapid automated detection of large vessel occlusions and intracranial hemorrhages on CT scans, reducing critical door-to-needle treatment times.
Apollo Hospitals & Qure.ai Dec-25 Apollo Hospitals implemented Qure.ai's qER triage platform across its entire healthcare network. The enterprise-wide integration utilizes deep learning algorithms to automatically prioritize acute stroke cases on imaging, optimizing critical-care pathways and diagnostic speed within the clinical golden hour.
Heidi Health Oct-25 Heidi Health secured USD 65 million in Series A funding to expand its large language model-powered medical scribe platform globally. This capital injection accelerates the commercialization of specialized ambient clinical documentation tools that automate note-taking and referral generation, optimizing clinical workflows and reducing administrative burdens.
HelloCareAI Apr-25 HelloCareAI secured USD 47 million in capital funding to scale its AI-driven virtual care platform for smart hospitals. The corporate investment expands the market reach of its AI-assisted nursing and remote monitoring systems, directly influencing commercial scalability and operational footprints in inpatient care infrastructure.
Innovaccer Feb-25 Innovaccer launched "Agents of Care," a new portfolio of generative AI-powered virtual assistants designed for clinical environments. The specialized software tools automate routine administrative tasks and patient documentation, introducing functional differentiation to alleviate healthcare professional burnout.
Huawei Sep-24 Huawei commercialized its Medical Technology Digitalization 2.0 Solution, embedding high-performance artificial intelligence capabilities into hospital computing architectures. The enterprise launch targets precision healthcare delivery by providing the necessary computing infrastructure to support real-time data analysis and medical imaging.
Qure.ai & Strategic Radiology Jun-24 Qure.ai partnered with Strategic Radiology to deploy its diagnostic artificial intelligence algorithms across the consortium's imaging networks. The operational deployment embeds automated imaging analysis directly into radiology workflows, increasing diagnostic accuracy and scaling clinical throughput.
Microsoft & NVIDIA Mar-24 Microsoft partnered with NVIDIA to integrate Azure's cloud infrastructure with NVIDIA's DGX Cloud and Clara software suite. This strategic technical collaboration establishes a high-performance generative AI computing environment tailored for clinical research, digital health solutions, and computer-aided drug discovery.
NVIDIA Mar-24 NVIDIA commercialized a series of Generative AI Microservices optimized for medical technology, digital health, and molecular biology. The launch introduces cloud-native infrastructure modules that allow healthcare technology developers to build, customize, and deploy secure generative AI models.
Report Customization

Customize Your Report

Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.

1 Custom Segments 2 Custom TOC 3 Related Reports

Artificial Intelligence (AI) in Healthcare Market — Custom Segments

Segment Sub-Segment
Workflow Automation Level Decision Support, Human-in-the-Loop Automation, Partial Workflow Automation, End-to-End Workflow Automation
AI Model Ownership Proprietary In-House Models, Vendor-Owned Models, Open-Source Models, Hybrid Models
AI Decision Role Descriptive & Predictive Insights, Clinical Decision Support, Operational Decision Support, Autonomous Decision-Making

Artificial Intelligence (AI) in Healthcare Market — Custom TOC

Custom Chapter Custom Details
Healthcare AI Use Case Prioritization
  • Clinical and Administrative Use Case Landscape
  • Use Case Attractiveness and Feasibility Assessment
  • High-Value AI Applications by Healthcare Setting
  • Adoption Pathways and Implementation Priorities
AI Adoption Readiness Assessment
  • Healthcare Organization AI Maturity Framework
  • Data, Infrastructure and Talent Readiness
  • Organizational and Governance Preparedness
  • Readiness Gaps and Capability-Building Priorities
  • AI Scaling Readiness Outlook
AI-Powered Healthcare Workflow Transformation
  • Workflow Automation Opportunity Areas
  • Clinical Decision Support Transformation
  • Patient Engagement and Care Delivery Evolution
  • Operational Workflow Redesign
  • Human–AI Collaboration Models

Need a different cut of the data?

Request Custom Research
Frequently Asked Questions

What is the current size of the artificial intelligence (AI) in healthcare market?

The market size of the artificial intelligence in healthcare is estimated at USD 66.48 billion in 2027.

What are the growth projections for the artificial intelligence in healthcare industry?

Artificial Intelligence in Healthcare Market size was estimated at USD 50.7 billion in 2026 and is projected to grow at a 36.96% CAGR from 2027 to 2036, reaching USD 1.18 trillion by 2036.

How is AI-driven clinical decision support influencing purchasing decisions in healthcare organizations?

Clinical decision support tools are driving adoption because they integrate directly into diagnostic and treatment workflows. By improving diagnostic accuracy, prioritizing high-risk cases, and reducing uncertainty, AI shortens time to intervention and aligns purchasing decisions with measurable improvements in clinical efficiency and outcomes.

What role do expanding healthcare datasets and workforce shortages play in accelerating AI adoption across clinical and operational workflows?

Expanding data from EHRs, imaging, labs, and genomics enhances predictive capability, making AI more actionable for risk detection and patient stratification. At the same time, workforce shortages are accelerating demand for automation in documentation, triage, scheduling, and routine interpretation tasks to reduce workload pressure.

Why do Software Solutions lead the artificial intelligence (AI) in healthcare market?

Software Solutions captured a 48.76% share in 2026 by serving as the primary platform for integrating AI algorithms, clinical workflows, imaging, and decision-support tools into existing healthcare infrastructure.

Why is Context-Aware Computing the fastest-growing technology segment in the artificial intelligence (AI) in healthcare market?

Context-Aware Computing is growing rapidly because healthcare providers increasingly require AI systems that adapt to changing patient and care environments, delivering more responsive and situationally relevant insights.

What keeps North America ahead in AI healthcare adoption?

North America captured 56.70% share in 2026 through advanced healthcare infrastructure, AI integration across workflows, and strong technology investment ecosystems.

Why is Asia Pacific becoming a key AI healthcare growth region?

Asia Pacific is growing at a 41.03% CAGR as healthcare systems adopt AI for diagnostics, automation, and data-driven care management.

Who are the leading players in the artificial intelligence in healthcare landscape?

Key players in the artificial intelligence in healthcare market include Microsoft Corporation (United States), Alphabet Inc. (United States), IBM Corporation (United States), NVIDIA Corporation (United States), Intel Corporation (United States), GE HealthCare Technologies Inc. (United States), Medtronic plc (Ireland), Oracle Corporation (United States), IQVIA Holdings Inc. (United States), Merck & Co., Inc. (United States).
Testimonials

Our Clients

"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."

Project Manager
Siemens Healthcare

"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."

Research and Development (R&D) Manager
GC Biopharma

"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."

Quality Assurance Manager
Medtronic
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →